Sai Life, a company in the Pharmaceuticals industry, reported revenue of ₹659 crore and net profit of ₹98 crore for the September 2026 quarter.
Sai Life (NSE: SAILIFE) closed at ₹1,800.70 on 20 Nov 2026, up 106.0% over the past year. Its market capitalisation is ₹38,279 crore and it trades at 100.2 times earnings.
Incorporated in 1999, Sai Life Sciences Ltd carries out contract research and manufacturing activities for customers engaged in pharmaceutical and bio technology industries
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.